Serum neuron-specific enolase and immunohistochemical markers of neuroendocrine differentiation in lung cancer
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
An enzyme immunoassay for serum neuron-specific enolase (NSE) was evaluated with respect to analytical performance and clinical utility and compared with immunohistochemical evaluation of neuroendocrine differentiation. Values obtained agreed well with values obtained using a radioimmunoassay method giving a correlation coefficient of 0.934. Analytical performance of the enzyme immunoassay was good but the diagnostic sensitivity of 82 % in extensive and 67% in limited disease was insufficient for serum NSE to be of value in the diagnosis of small cell lung cancer (SCLC). Serum NSE decreased significantly in 11 of 15 patients with SCLC following institution of chemotherapy. Classification of lung cancers into SCLC and non small cell lung cancer (NSCLC) types is largely based on tumour morphology. Neuroendocrine differentiation may not be morphologically evident. Immunohistochemical staining of tumour tissue with markers of neuroendocrine differentiation, i.e. NSE (both monoclonal and polyclonal antibodies) Leu 7, Chromogranin A and P G P 9.5 was performed in both patients with SCLC and NSCLC. 38 per cent of patients with NSCLC had both raised serum NSE and positive NSE (polyclonal) immunoperoxidase staining of lung tissue. A further 35 per cent of patients showed a raised serum NSE or positive immunohistochemistry but not both. The presence of two positive immunoperoxidase markers in lung tissue has been suggested as an indicator of responsiveness to chemotherapy in NSCLC patients. A number of factors may affect immunohistochemical positivity in tissue sections and the additional use of a serum marker may better define chemotherapy responsive groups.
- Carney, D. N., Marangos, P. J. Ihdedc, Bunn, P. A. et al. Serum Neuron-Specific Enolase; a marker for disease extent and response to therapy of small cell lung cancer. The Lancet 1982; 13: 583–586. CrossRef
- Lamb, D. Lung cancer and its classification. Anthony, P. P. and McSweeney, W. W. (Eds). Recent Advances in Histopathology. No. 13 Churchill Livingstone/RNM Edinburgh 1987; 13: 45–59.
- Baylin, S. B. Neuroendocrine differentiation: A prognostic feature of non-small cell cancer. J. Clin. Oncol. 1989; 7: 1375–1376.
- Addis, B. J. Hamid, Q., Ibrahim, N. B., Fahey, M., Bloom, S. R., Polak, J. M. Immunohistochemical markers of small cell carcinoma and related neuroendocrine tumours of the lung. J. Pathol. 1987; 153: 137–150. CrossRef
- Visscher, D. W., Zarbo, R. J., Trojonawski, J. Q., Sakr, W., Crissman, J. D. Neuroendocrine differentiation on poorly differentiated lung carcinoma; a light microscopic and immunohistologic study. Mod. Pathol. 1990; 153: 508–512.
- Bergh, J., Esscher, T., Steinholtz, L. et al. Immunocytochemical demonstration of neuron-specific enolase (NSE) in human lung cancers. Am. J. Clin. Pathol. 1985; 84: 1–7.
- Linnoila, R. I., Mulshine, J. L., Steinberg, S. M. et al. Neuroendrine differentiation in endocrine and nonendocrine lung carcinomas. Am. J. Clin. Pathol. 1988; 90: 641–652.
- Crompton, G. Small Cell Lung Cancer. BMJ 1990; 3000: 201–210.
- Souhami, R.L. Neuroendocrine phenotype,chemosensitivity and prognosis in adenocarcinoma of the lung. Ann. of Oncol, 1991; 2: 323–324.
- Graziano, S. L., Mazid, R., Newman, N. et al. The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non small cell lung cancer. J. Clin. Oncol. 1989; 7: 1398–1406.
- Jorgensen, L. G. M., Hirsch, F. R., Skov, B. G. Osterlind, K., Cooper, E. H., Larsson, L. I. Occurence of neuronspecific enolase in tumour tissue and serum in small cell lung cancer. Br. J. Cancer. 1991; 63: 151.
- Reidy, J. A., Skoczenski, B. A., Bleile, D. M., Usategui, M. An enzyme immunoassay for the detection of gamma-enolase in serum. Clin. Chem. 1987; 33: 928–929.
- Cooper, E. H., Splinter, T. W. A., Brown, D. A., Muers, M. F., Peake, M. D., Pearson, S. L. Evaluation of a radioimmunoassay for Neuron Specific Enolase in Small Cell Lung Cancer. Br. J. Cancer 1985; 52: 333–338.
- Hsu, S. M., Raine, L., Fanger, H. Use of Avidin-Biotin Peroxidase Complex (ABC) in immunohistochemical techniques. J. Histochem. Cytochem. 1981; 29: 577–580.
- Johnson, D. H., Marangos, P. J., Forbes, J. et al. Potential utility of Neuron Specific Enolase levels in small cell carcinomas of the lung. Cancer Research 1984; 44: 5409–5414.
- Akoun, G. M., Scarna, H. M., Milleron, B. J., Benichou, M. P. Herman, D. P. Serum Neuron Specific Enolase a marker for disease extent and response to therapy for small cell lung cancer. Chest 1985; 87: 39–49. CrossRef
- Splinter, T. A., Cooper, E. H., Kho, G. H., Oosteron, R., Peake, M. D. Neuron Specific Enolase as a guide to the treatment of small cell lung cancer. Eur. J. Cancer Clin. Oncol. 1987; 23: 171–176. CrossRef
- Burghuber, O. C., Worofka, B., Schernthanerg, G. et al. Serum Neuron Specific Enolase is a useful tumour marker for small cell lung cancer. Cancer 1990; 65: 1386–1390. CrossRef
- Teeling, M., McGing, P., Johnston, P., Carney, D. N. Clinical correlation of tumour endocrine markers in lung cancer. In: Hansen, H. H. (Eds) Basic and clinical concepts of lung cancer. Kluwer Academic Publishers 1989, chapter 9.
- Carney, D. N. Biology of small cell lung cancer. The Lancet 1992; 339: 843–845. CrossRef
- Esscher, T., Steinholtz, L., Bergh, T., Nou, E., Nilsson, K., Pahlman, S. Neuron Specific Enolase: A useful diagnostic serum marker for small cell carcinoma of the lung. Thorax. 1985; 40: 85–90.
- Beasteall, G. H., Cooke, B., Rustin, G. J. S. et al. A review of the role of established tumour markers. Ann. Clin. Chem. 1991; 28: 5–18.
- Van Zandwijk, N., Jassem, E., Bonfrer, J. M. G. et al. Value of Neuronspecific enolase in early detection of relapse in small cell lung carcinoma. Eur. J. Cancer, 1990; 26: 373–376. CrossRef
- Jorgensen, L. G. M., Osterlind, K., Hansen, H. H. et al. The prognostic influence of serum neuron-specific enolase in small cell lung cancer. Br. J. Cancer 1988; 58: 805–807.
- Said, J. W., Vimadalal, S., Nash, G. et al. Immunoreactive neuronspecific enolase, bombesin and chromogranin as markers for neuroendocrine lung tumours. Hum. Pathol. 1985; 16: 236–240. CrossRef
- Watts, A. E., Said, J. W., Shintaku, I. P. et al. Chromogranin as a marker of neuroendocrine cells in cytologie material: An immunochemical study. Am. J. Clin. Pathol. 1985; 84: 273–277.
- Bordi, C., Pilatio, F. P., D’Adda, T. Comparative study of seven neuroendocrine markers in pancreatic endocrine tumours. Virchows Archiv-A-Pathol. Anat. 1988; 413: 387–398. CrossRef
- Thomas, P., Battifora, H., Mandenno, G.L.etal. Amonoclonal antibody against neuron-specific enolase. Am. J. Clin. Pathol. 1987; 88: 146–152.
- Dhillon, A. P., Rode, J., Dhillon, D. P. et al. Neural markers in carcinoma of the lung. Br. J. Cancer 1985; 51: 645–652.
- Harding, M., McAllister, J., Mulkis, G. et al. Neuronspecific enolase (NSE) in small cell lung cancer: A tumour marker of prognostic significance. Br. J. Cancer 1990; 61: 605–6
- Skov, B. G., Sorensen, J. B., Hirsch, F. R. et al. Prognostic impact of histological demonstration of chromogranin A and neuron-specific enolase in pulmonary adenocarcinoma. Ann. Oncol. 1991; 2: 355–360.
- Serum neuron-specific enolase and immunohistochemical markers of neuroendocrine differentiation in lung cancer
Irish Journal of Medical Science
Volume 164, Issue 1 , pp 31-36
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Department of Biochemistry, St. Vincent’s Hospital, Dublin
- 2. Department of Histology, St. Vincent’s Hospital, Dublin
- 3. Department of Metabolism, St. Vincent’s Hospital, Dublin
- 4. Department of Oncology, St. Vincent’s Hospital, Dublin